Radient Pharmaceuticals Corporation fka RXPC

[primarywatcher]

Ironridge Global is a private equity firm providing innovative financial solutions for small cap public companies traded on exchanges worldwide. The firm acts as a passive capital partner geared to provide the lowest available cost of capital. Ironridge Global has developed processes enabling the firm to quickly structure flexible financial solutions based upon each company’s unique situation, perform expedited and streamlined due diligence, make decisions and close transactions quickly and efficiently.

Transactions completed with Ironridge Global are far superior to traditional registered directs, PIPES or equity lines. Ironridge is not a hedge fund, does not request anti-dilution protection, or require any restrictive covenants.

The principals of Ironridge Global have completed billions of dollars in private placements and public offerings of debt and equity securities over the last 20 years, with extensive industry expertise in life sciences, biotechnology, cleantech, energy, consumer products, technology, oil and and gas, natural resources and emerging growth companies.

http://www.ironridgeglobal.com/?page_id=2